Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost side effects of Mounjaro are gastrointestinal, most are mild, and most ease within a week or two of starting or after a dose change. Knowing how to reduce them — through timing, food choices and simple habits — makes a real difference for most people on treatment. Mounjaro (tirzepatide) is a prescription-only medicine, so any adjustments to how you manage side effects should be discussed with your prescriber. This page covers what the evidence and clinical guidance say, so you go into that conversation prepared. The NHS tirzepatide medicines page is a good starting point for the full list of known effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows the rate at which your stomach empties and acts on appetite centres in the brain. Both effects are why the medicine works, and both are why some people feel nauseous, especially in the first week or after moving up a dose. The slow gastric emptying that curbs hunger can also back up digestion, which explains why constipation and bloating are just as common as loose stools for some people.
There is a persistent idea that side effects mean the treatment is working especially well. That is not quite accurate. They reflect your gut adjusting to a new pattern of signalling, nothing more. Managing them does not blunt the medicine's effect on weight.
The most consistent advice from prescribers is to eat smaller portions, more slowly, and stop before you feel full. Because Mounjaro slows emptying, a meal that would have been fine before treatment can tip into discomfort. Cutting back on high-fat and heavily processed food during the first few weeks reduces the load on a system that is already adjusting. For more detail on the full range of Mounjaro side effects, including less common ones, that page covers the complete picture from the clinical data.
A few practical changes come up repeatedly in clinical guidance and in what patients tell prescribers. None of them require anything complicated.
Hydration matters more than most people expect. Reduced appetite means some people simply forget to drink. Mild dehydration makes nausea worse and can compound constipation. Aiming for six to eight glasses of water across the day (separately from meals rather than during them) is worth building into your routine.
Injection timing is worth experimenting with, within what your prescriber recommends. Some people find that injecting on an evening when they plan a lighter dinner suits them better than a morning injection before a full day. The approaches to stopping Mounjaro side effects page goes deeper on timing, injection sites and the early-week pattern many people experience.
Ginger (in tea or a plain biscuit) has reasonable evidence for mild nausea and is safe alongside tirzepatide. Over-the-counter antiemetics are a different matter; check with your prescriber or pharmacist before adding anything, because Mounjaro's effect on gastric emptying can alter how quickly other medicines are absorbed. That absorption question is also why women on oral contraceptives should add a barrier method for the first four weeks of treatment and after each dose increase, NHS England's weight management guidance covers this clearly.
Fibre intake helps with both constipation and loose stools, depending on type. Soluble fibre (oats, lentils, soft fruit) is gentler; insoluble fibre (bran, raw veg) can worsen bloating in the early weeks. Small adjustments rather than wholesale diet changes tend to work better when your appetite is already reduced.
Yes, and this distinction matters. The MHRA issued a Drug Safety Update in January 2026 specifically drawing attention to acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including tirzepatide. The symptom pattern to know is severe stomach pain that reaches through to the back, sometimes accompanied by vomiting, that does not ease within a short time. This is not the ordinary nausea of the first week. It needs same-day medical assessment, call 111, go to an urgent treatment centre, or attend A&E if the pain is intense.
Other situations that warrant prompt contact with a healthcare professional include: signs of significant dehydration (dizziness when standing, very dark urine, inability to keep fluids down for more than a few hours), a suspected allergic reaction (swelling of the face or throat, difficulty breathing, a severe rash), and any new or worsening low mood or thoughts of self-harm. The link between Mounjaro and anxiety is explored separately, with the current evidence on psychological effects.
For suspected pancreatitis specifically, the steps for reducing pancreatitis risk on Mounjaro are covered in detail, including who may be at higher baseline risk and what to tell your prescriber before you start.
If you experience a side effect you were not expecting or that does not settle, you can report it directly to the MHRA using the Yellow Card scheme. You can also report via the patient section of that site, not just through a healthcare professional.
The titration schedule (starting at 2.5mg and stepping up under prescriber guidance) exists precisely to let your system adapt before doses increase. Rushing that schedule is the single most common reason side effects become unmanageable. At nume, every dose increase is reviewed by a GPhC-registered prescriber before it is approved; evidence of how you have tolerated the current dose is part of that review, not a formality.
If side effects are genuinely disrupting daily life, the right move is to tell your prescriber. Staying at the current dose for longer, or occasionally stepping back a dose, are both recognised approaches in clinical practice. The five most commonly reported Mounjaro side effects page is a useful reference if you want to benchmark what you are experiencing against what trials showed.
Our prescribers discuss suitability and side effects as part of every consultation, not just at the start, but at each review. If you are still considering whether treatment is right for you, checking your eligibility is the natural next step. You can also read about Mounjaro's licensed use in the UK and what the treatment involves before making any decisions.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.